Clinical trial
Spironolactone in Diabetic Nephropathy
NCT00317954 · Steno Diabetes Center Copenhagen, Other · Completed
Key facts
| NCT number | NCT00317954 |
|---|---|
| Title | Spironolactone in Diabetic Nephropathy |
| Official title | Spironolactone in Diabetic Nephropathy |
| Lead sponsor | Steno Diabetes Center Copenhagen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | Spironolactone |
| Enrollment | 48 |
| Start date | Sep 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Apr 25, 2006 |
| Last update posted | Apr 25, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: